Thyroid Medication Recall: Check Your Bottle for This Lot Number
A nationwide thyroid medication recall now affects one lot of Thyroid Tablets, USP 30 mg, after FDA testing found the pills could be dangerously superpotent. Vitruvias Therapeutics issued the voluntary recall on September 1 for Lot 504950, and the risk is especially serious for older adults, who make up the majority of thyroid medication users and face the highest danger from an overactive thyroid.
Why This Thyroid Medication Recall Matters to You
Hypothyroidism, an underactive thyroid, disproportionately affects women over 60, and thyroid replacement medication is one of the most commonly prescribed drugs among older adults. Taking a superpotent version can push the body into hyperthyroidism instead — an overactive thyroid with symptoms including rapid heart rate, chest pain, dangerous heart rhythm disturbances, high blood pressure, and unintended weight loss.
The FDA specifically flagged elderly patients as facing the greatest risk, particularly with extended use, because the cardiac strain from excess thyroid hormone compounds existing heart conditions common in older adults.
Key Facts & Context
The recalled lot — Lot 504950, NDC 69680-166-00 — was distributed nationwide to pharmacies between January 31 and September 30, 2025, with an expiration date of September 30, 2026. Vitruvias Therapeutics, based in Auburn, Alabama, released 3,655 units, of which 1,955 were sold to consumers before the recall.
As of the recall announcement, the company said it had not received any adverse event reports linked to the affected lot. Still, the FDA is urging anyone taking this medication to check their bottle immediately rather than wait for symptoms to appear. Because the affected units were distributed broadly to pharmacy accounts nationwide, consumers cannot assume their location is exempt simply because it’s outside a particular region.
What to Do If You Take Thyroid Medication
How do I check if my bottle is affected?
Look at the label on your Thyroid Tablets, USP 30 mg bottle for Lot 504950 and NDC 69680-166-00. This information is usually printed near the expiration date on the side or bottom of the container.
Should I stop taking my medication right away?
If your bottle matches the recalled lot, contact your pharmacist or prescribing doctor before you stop taking it — suddenly discontinuing thyroid medication carries its own risks. Your provider can arrange a replacement from an unaffected lot.
What symptoms should I watch for?
Contact your doctor promptly if you notice a racing heartbeat, chest pain, unexplained weight loss, heat intolerance, or new nervousness or muscle weakness — all signs of excess thyroid hormone that warrant evaluation.
Explore more: For tools to help track medications and home health routines, visit Home360.
Related reading: managing multiple medications safely and recognizing thyroid symptoms after 50.
Looking Forward
Medication recalls like this one are a reminder to periodically check the lot numbers on long-term prescriptions, especially maintenance drugs like thyroid hormone that millions of older adults take daily. If you’re unaffected, no action is needed beyond your normal refill schedule — but it’s worth keeping this recall in mind the next time you pick up a prescription. A quick habit worth adopting: photograph the lot number on every new prescription bottle so you have it on hand if a future recall notice arrives.